Summary The antigenic phenotype, ultrastructure and bone resorbing ability of mononuclear and multinucleated giant cells of four giant cell tumour of tendon sheath (GCTTS) lesions was assessed. Both the giant cells and the mononuclear cells exhibted the antigenic phenotype of cells of the monocyte/macrophage lineage. The giant cells, unlike osteoclasts, did not respond morphologically to calcitonin and showed ultrastructural and immunophenotypic features of macrophage polykaryons. However (Wood et al., 1988) , and do not support the concept that the lesion is a form of xanthoma or benign fibrous histiocytoma (Rosai, 1981) .
Giant cell tumour of tendon sheath (GCTTS) is a benign lesion composed of cellular fibrous tissue in which there are numerous mononuclear histiocyte-like cells and multinucleated giant cells (Enzinger & Weiss, 1983) . Foamy macrophages and hemosiderin, some of which is present in macrophages, are also present. The origin and nature of the cell types found in GCTTS is unclear. Ultrastructural studies have shown similarities between some of the mononuclear cells in GCTTS and Type A (histiocyte-like) and Type B (fibroblast-like) synovial lining cells with the giant cells apparently derived from fusion of the Type A synovial lining cells (Alguacil-Garcia et al., 1978; Eisenstein, 1968) . Other studies have suggested that the mononuclear cell component resembles osteoblasts and the giant cell component, osteoclasts (Carstens, 1978) . Recent immunohistochemical studies have also suggested that the giant cells are osteoclasts and that cells in the lesion show true histiocytic differentiation (Wood et al., 1988) , and do not support the concept that the lesion is a form of xanthoma or benign fibrous histiocytoma (Rosai, 1981) .
There have been several recent studies on the nature of giant cells in giant cell lesions of bone and soft tissue which have used bone resorption as an operational or functional criterion to determine whether tumour-associated giant cells present in a pathological lesion are osteoclasts (Athanasou et al., 1983; Flanagan & Chambers, 1988; Flanagan & Chambers, 1989) . In this way, giant cells derived from a giant cell reparative granuloma of the jaw (Flanagan & Chambers, 1988) and giant cells from a giant cell rich malignant fibrous histiocytoma (Flanagan & Chambers, 1989) were considered to be osteoclasts. However, it has recently been shown that tumour-associated macrophage polykaryons derived from a primary breast carcinoma are also able to resorb bone (Athanasou et al., 1989) . This result appeared inconsistent with the general belief that no polykaron other than an osteoclast is capable of bone resorption (Chambers & Horton, 1984) .
In this study, we Four GCTTS lesions were examined. These were from the left index finger of a 37 year old female, the right index finger of a 58 year old male and the right and left middle fingers of a 45 year old male. In all cases, part of the lesion was fixed in formalin and processed routinely. For transmission electron microscopy, tiny samples of tissue were fixed in 4% phosphate buffered glutaraldehyde for 6 h, then post-fixed_in 2% buffered osmium tetroxide for 2 h. Tissue was dehydrated in graded alcohol, treated with propylene oxide and embedded in epoxy resin (EMix). Thin sections were stained with uranyl acetate and lead citrate, and examined in a Jeol 100 CX electron microscope. Samples of the tumour were also snap-frozen in liquid nitrogen and then stored at -220C for cytostate sectioning. Several antigenic determinants were sought in cryostat sections of the lesions after the application of monoclonal antibodies listed in Table I . These antibodies were derived from the Third and Fourth Workshops on Human Leucocyte Differentiation Antigens (Hogg & Horton, 1987; Knapp et al., 1989) . Immunohistochemistry was performed using an indirect immunoperoxidase technique (Gatter et al., 1984) .
Preparation of isolated macrophages and macrophage polykaryons The remainder of the tissue was placed in normal saline and then transferred to Hanks BSS (Gibco). The tumour was cut into small pieces, digested for 2 h in Hanks containing 10 mg ml-' collagenase type II (Sigma). The solution was then centrifuged and the resulting cell pellet dissolved in 5 ml of RPMI 1640 (Gibco) containing 10% foetal calf serum (RPMI/FCS). Phase contrast examination of this suspension revealed large numbers of multinucleated cells interspersed amongst abundant mononuclear cells. Br. J. Cancer (1991), 63, 527-533 '." Macmillan Press Ltd., 1991 Response to calcitonin The cell suspension was added to the wells of a 16 mm diameter Costar plate containing 15 mm glass coverslips; these were incubated for 30 min at 37°C in 5% CO2. The coverslips were then removed from these wells and washed vigorously to remove non-adherent cells. One of a pair of coverslips was then placed in a well containing CT (1 pg ml-'), the other in control tissue culture medium. The cells were observed by phase contrast microscopy for 1 h to determine if their was any morphological response to calcitonin (Chambers & Magnus, 1982) , after which they were fixed in formalin for Giemsa staining. This procedure was repeated with cells incubated on coverslips overnight in RPMI/FCS.
Cell culture on bone slices The cell suspension was added to the wells (16 mm diameter) of a tissue culture plate (Costar, UK) containing four cortical bone slices prepared as previously described , or to 15 mm glass coverslips. The cell suspension was incubated on these for 60 min at 37°C. The bone slices and the coverslips were then removed, washed vigorously in MEM and placed in fresh 16 mm diameter wells (two bones per well). For the bone slices, these contained one of the following: PTH (10 IU ml-'), PGE2 (10-M), CT (1 g ml-'), 1.25 (OH)2D3 (10-`M), interleukin-l (IL-1) (10 ng ml-') or appropriate vehicle controls in 1 ml of RPMI/FCS. These were incubated for periods of 3 and 7 days. Two bone slices from each of these cultures was fixed in 4% glutaraldehyde in 0.2 M cacodylate buffer for 2 h. The other two bone slices were placed in Triton X-100 (0.1% in distilled water) for 6 h before glutaraldehyde fixation. This treatment removes all cells from the bone surface and allows the underlying substrate to be examined for evidence of bone resorption. The specimens were dehydrated through a graded ethanol series and critical point dried from CO2. Specimen were sputter coated with gold and examined in a Philips SEM 505 scanning electron microscope.
The number of giant cells on the bone slices and the number of resorption pits on the corresponding Tritontreated bone slices which had shared the same well were counted in cultures incubated for 3 days and 7 days. The surface area of each resorption pit was calculated by tracing the outline of the pit on to a digitising tablet linked to a Kontron MOP AMO3 image analyser.
The coverslips containing cell suspension were also incubated in RPMI/FCS for 24 h, 3 days and 7 days in order to assess the number and nature of the cells after these periods of incubation. These were fixed in cold acetone and the histiocytic nature of the cells present on the coverslips confirmed by immunohistochemistry with monoclonal antibody EBM/l (Kelly et al., 1988) .
Controls
To confirm the validity of the CT response and the bone resorption assay, rodent osteoclasts were isolated and cultured as previously described . These showed respectively an inhibitory response to salmon CT and production of numerous resorption pits on bone slices. (Figure lb) . Golgi bodies were also present, Response to calcitonin and morphology of cell cultures on coverslips Both mononuclear cells and multinucleated giant cells, which had settled immediately after isolation onto glass coverslips, rapidly expanded their cytoplasm and were highly motile. The giant cells had an abundant, well spread, pale staining cytoplasm which in some cells appeared vacuolated. They had a smooth outline and often extended broad pseudopods. Unlike osteoclasts, which become immotile and retract cytoplasmic pseudopods almost immediately after exposure to calcitonin, the giants cells remained motile and retained their broad cytoplasmic outlines. Mononuclear cells were of two types; one spindle shaped, the other a round or ovoid cell with one or more small or large pseudopodal extensions. Motile, mononuclear cells were also noted and these showed no response to calcitonin treatment.
Results

Histopathology
The morphological appearance of the mononuclear and multinucleated cells did not change after incubation for 24 h, 3 and 7 days, although the number of round and spindle shaped mononuclear cells increased. Most of the round and spindle shaped mononuclear cells as well as the multinucleated cells reacted with EBM/11 for the CD68 macrophageassociated antigen.
Cell culture on bone slices and bone resorption by GCTTS cells Multinucleated cells were easily distinguished from scattered small mononuclear cells by their large size (up to 100 microns) and complex surface specialisations; these included scattered fine microvilli and numerous ruffles over their free (upper) surface and pseudopodal extensions. At the edge of the cell body, there were numerous filopodia or retraction fibres which anchored the cell to the bone surface. Several large multinucleated cells were flattened against the bone surface and had few surface specialisations. predominantly adjacent to the nuclei (Figure lb) . Around the periphery of the cells was a narrow (120 nm wide) organelle free zone consisting of fine filaments. The plasmalemma was relatively smooth although certain areas exhibited numerous finger-like or bulbous projection (Figure lb) .
In certain cases, the giant cells were surrounded by collagen filaments while others were admixed with 'mononuclear' cells (Figure la) . In these latter examples, many of the 'mononuclear' cells had a similar nuclear and cytoplasmic morphology to those of the giant cells (Figure la) .
Immunohistochemistry
Both mononuclear cells and multinucleated giant cells expressed numerous leucocyte and macrophage-associated antigens including CD45 (leucocyte common antigen -LCA), CD13, CD14, and CD68 (macrophage-associated antigens) (Table I) (Figure 2) . They also expressed all the leucocyte integrin antigens, CD1 la (LFA-1), CD1 lb (CR3), CD1 lc (p150,95) and CD18 (Figure 2) . The giant cells expressed HLA-DR, transferrin receptor (CD7 1) and receptors for complement (CD1 ib, CD35) and Fc components (CD16, CD32, CD64) of immunoglobulin (Figure 2) . The plump and spindle shaped mononuclear cells showed expression of a similar range of antigens. Both mononuclear and multinucleated cells also expressed CD51 and CD61, the alpha and beta chains respectively of the vitronectin receptor. The small mononuclear cells were either spindle shaped or rounded and contained numerous ruffles and microvilli over the cell body. These frequently contained fine and broad pseudopodal extensions.
Bone resorption by GCTTS cells In all cell cultures on bone slices, there was evidence of bone resorption associated with large presumed multinucleated cells (Figure 3a) . This was essentially of two types. The first closely resembled osteoclast resorption pits and included circular, serpiginous and compound excavations (Figures 3b  and 3c) . Although a few large resorption areas were seen, the majority (>95%) of pits were less than 500gm2; this size is generally smaller than resorption pits associated with rodent and giant cell tumour of bone-derived osteoclasts. In addition, very few pits were formed given the number of giant cells present on the bone slices (Table II) . Secondly, associated with both small mononuclear and large multinucleated cells were poorly defined areas of discernible surface roughening or resorption (Figure 4 ). These areas of surface alteration contrasted with the surrounding smooth bone surface by containing exposed mineralised collagen fibres. The areas were generally concentrated around large cells, which often formed cell clusters. They were also seen in the vicinity of resorption pits and in some cases merged with the edges of an otherwise well-defined resorption pit.
Osteotropic hormones had no significant effect on bone resorption (Table II) .
Discussion
The immunohistochemical findings show that GCTTS is composed of cells of histiocyte differentiation. The giant cells express a similar antigenic phenotype to that of mononuclear cells and would appear to form by fusion of these cells. The histocytic nature of the mononuclear cells would appear to distinguish them from both osteoblasts and mononuclear cells of fibrohistocytic lesions (Wood et al., 1986) . However, the possibility that these cells are of synovial origin cannot be excluded as cells of the monocyte/macrophage lineage are found within or lining synovial tissue (Edwards, 1982; Athanasou et al., 1988) . Synovial lining cells have an antigen phenotype which closely resembles that of tissue macrophages being characterised by weak or low frequency expression of CD Ila and also CDlIc (Hale et al., 1989; Allen et al., 1989) , features not noted in the cases studied.
The giant cells of GCTTS expressed a wide range of monocyte/macrophage-associated antigens including CD 14 and the leucocyte integrins CD1la,b,c and CD18 (LFA family). They also expressed receptors for Fc and complement components as well as HLA-DR. The osteoclast antigenic phenotype is characterised by absence of these antigens and expression of a highly restricted range of macrophageassociated antigens ). The giant cell antigenic phenotype resembled that of tissue macrophages, a feature characteristic of macrophage polykaryons . Consistent with this, we found that the immunohistochemical staining pattern of most mononuclear and multinucleated cells in the GCTTS was identical. This extended to expression of CD51 (a chain of the vitronectin receptor), an antigen that was formerly thought to be osteoclast-specific (Horton et al., 1985) but is now known to be present on a variety of cell types including foreign body macrophage polykaryons .
In a previous enzyme histochemical and immunohistochemical study of GCTTS, the giant cells were considered to resemble osteoclasts largely on the basis of enzyme activity for acid phosphatase, ATP'ase, beta glucuronidase, alpha naphthyl acetate esterase and 5' nucleotidase; macrophages and sinus histiocytes contained more naphthyl acetate esterase and less acid phosphatase than osteoclasts (Wood et al., 1988) . None of these enzymes are specific for monocytes, macrophages, their fused products or osteoclasts (Gothlin & Ericsson, 1976; Papadimitriou & Walters, 1989) . Wood et al. (1988) also found that GCTTS giant cells expressed leucocyte common antigen and several macrophage markers including HLA-DR and CD14, antigens which are not present on osteoclasts. However, expression of these antigens (confirmed in the present study) is characteristic of macrophage polykaryons . As in the present study, mononuclear cells and giant cells expressed a similar antigen phenotype. Confirmation that the giant cells of GCTTS are macrophage polykaryons is seen in their lack of morphological response to CT (Chambers & Magnus, 1982) and their ultrastructural features which show no evidence of ruffled border formation although the latter is only seen adjacent to a bone substrate (Gothlin & Ericsson, 1976) . The numerous polyribosomes and rER cisternae and the fine filament bundles in the subplasmalemmal zone noted in this and previous studies (Alguacil-Garcia et al., 1978) are also consistent with the giant cells of the lesion studied being designated macrophage polykaryons (Papadimitriou & Walters, 1979 ). Murrills et al. (1989 noted that human osteoclasts showed a variable, occasionally absent response to CT; they used human CT which is less potent than the salmon CT used in this and other studies which have shown a CT effect on human osteoclasts and osteoclast-like giant cells Athanasou et al., 1986) .
One of the features which the giant cells exhibited was the ability to produce characteristic resorption pits on bone slices. There have been several in vitro studies which provide indirect evidence that mononuclear phagocytes can degrade both the mineral and organic components of bone (Teitelbaum et al., 1979; Mundy et al., 1977; Fallon et al., 1983) . However, rodent macrophage polykaryons have been shown to lack the ability to produce resorption pits (Chambers & Horton, 1984) , a property which both rodent and human osteoclasts possess (Athanasou et al., 1983; Murrills et al., 1989) . Consequently, the ability to produce resorption pits is now employed as an operational or defining characteristic of a cell as an osteoclast Horton, 1988) .
Direct evidence of bone resorption in conjunction with a positive immunohistochemical reaction with anti-CD51 antibodies has been used to categorise giant cells from two giant cell lesions as osteoclasts (Flanagan & Chambers, 1988; Flanagan & Chambers, 1989) . However, it is now clear that anti-CD51 antibodies are not osteoclast-specific and that they also stain macrophage polykaryons . It has also recently been shown that macrophage polykaryons isolated from a breast carcinoma are capable of osteoclast-like bone resorption (Athanasou et al., 1989 ). These polykaryons, like those from the GCTTS, did not response to calcitonin and showed phenotypic and ultrastructural differences from osteoclasts. The degree and pattern of bone resorption by the polykaryons in both giant cell lesions also shows some similarities.
Although numerous GCTTS-derived giant cells were present on the bone slices, relatively few resorption pits being produced by these cells, even after incubation for several days. This pattern of bone resorption is completely different from that of rodent osteoclasts or the osteoclast-like giant cells of a giant cell tumour of bone , both of which produce numerous resorption pits on bone slices. Moreover, although a few large resorption areas were seen, the resorption pits produced by GCTTS and tumour-associated giant cells were generally smaller than those associated with osteoclasts as well as fewer in number (Flanagan & Chambers, 1988; Flanagan & Chambers, 1989; Athanasou et al., 1989) . In addition, cells isolated from the GCTTS produced poorly defined areas of surface roughening, a type of bone degradation which has previously been noted to be an uncommon form of osteoclastic bone resorption .
Recognition that macrophage polykaryons are capable of bone resorption is important for several reasons. First, it indicates that direct evidence of bone resorption is not in itself sufficient to define a polykaryon as an osteoclast. Secondly, it supports earlier studies which have indirectly shown that monocytes, macrophages and macrophage polykaryons are capable of bone degradation (Teitelbaum et al., 1979; Mundy et al., 1977; Fallon et al., 1983) . It also establishes another phenotypic similarity between these cells and the osteoclast. Recently, mononuclear and multinucleated cells, generated by long-term culture of bone marrow cells, have shown a limited ability to resorb bone (Kukita et al., 1989) . It has been suggested that such cells may represent mononuclear osteoclast precursors and osteoclasts respectively. However, the possibility that such bone-resorbing multinucleated cells are macrophage polykaryons rather than osteoclasts should also be considered.
Finally, the fact that bone resorption by macrophage polykaryons is characterised by fewer and smaller resorption pits than that of osteoclast-containing lesions indicates that there are differences in the pattern of polykaryon-associated osteolysis. This could account for differences in the clinical behaviour of osteolytic lesions such as tumour size, rate of growth or aggressiveness. This may be of significance with respect to the behaviour of the many different giant cell lesions of bone and soft tissue that are clinically associated with varying degrees of osteolysis, some of which has been shown to be due to giant cells (Rosai, 1981; Athanasou et al., 1983; Flanagan & Chambers, 1988; Flanagan & Chambers, 1989) . It could also conceivably influence the behaviour of osteolytic bony metastases where different pattern of osteoclast/giant cell bone resorption have been noted (Galasko, 1982) .
